Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial
Titel:
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial
Auteur:
Mavoko, Hypolite Muhindo Nabasumba, Carolyn da Luz, Raquel InocĂȘncio Tinto, Halidou D'Alessandro, Umberto Kambugu, Andrew Baraka, Vito Rosanas-Urgell, Anna Lutumba, Pascal Van geertruyden, Jean-Pierre
Verschenen in:
The Lancet global health
Paginering:
Jaargang 5 (2017) nr. 1 pagina's e60-e68
Jaar:
2017
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license